Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arteriovenous Shunt, Surgical | 12 | 2021 | 76 | 4.580 |
Why?
|
| Renal Dialysis | 18 | 2021 | 364 | 4.170 |
Why?
|
| Kidney Failure, Chronic | 16 | 2021 | 432 | 3.680 |
Why?
|
| Brachiocephalic Veins | 8 | 2021 | 33 | 2.360 |
Why?
|
| Blood Viscosity | 4 | 2017 | 15 | 0.970 |
Why?
|
| Hemodynamics | 3 | 2021 | 775 | 0.960 |
Why?
|
| Brachial Artery | 3 | 2021 | 36 | 0.930 |
Why?
|
| Fistula | 3 | 2017 | 42 | 0.880 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2020 | 100 | 0.830 |
Why?
|
| Blood Flow Velocity | 4 | 2021 | 201 | 0.800 |
Why?
|
| Models, Cardiovascular | 3 | 2020 | 110 | 0.750 |
Why?
|
| Computer Simulation | 4 | 2021 | 1158 | 0.730 |
Why?
|
| Thrombosis | 2 | 2023 | 326 | 0.680 |
Why?
|
| Arteriovenous Fistula | 1 | 2021 | 54 | 0.670 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 258 | 0.650 |
Why?
|
| Midodrine | 1 | 2018 | 5 | 0.590 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 340 | 0.580 |
Why?
|
| Hypotension | 1 | 2018 | 76 | 0.560 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2016 | 12 | 0.500 |
Why?
|
| Brachiocephalic Trunk | 1 | 2016 | 14 | 0.490 |
Why?
|
| Venous Insufficiency | 1 | 2015 | 11 | 0.470 |
Why?
|
| Central Venous Catheters | 1 | 2015 | 22 | 0.450 |
Why?
|
| Constriction, Pathologic | 3 | 2021 | 219 | 0.450 |
Why?
|
| Arginine | 2 | 2015 | 144 | 0.440 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 437 | 0.430 |
Why?
|
| Catheterization, Central Venous | 1 | 2015 | 120 | 0.430 |
Why?
|
| Diabetes Complications | 1 | 2015 | 175 | 0.410 |
Why?
|
| Models, Biological | 2 | 2021 | 1809 | 0.390 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 257 | 0.380 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2012 | 62 | 0.350 |
Why?
|
| Prospective Studies | 6 | 2020 | 4664 | 0.350 |
Why?
|
| Humans | 25 | 2023 | 95795 | 0.320 |
Why?
|
| Middle Aged | 14 | 2021 | 28207 | 0.300 |
Why?
|
| Stress, Mechanical | 3 | 2020 | 261 | 0.300 |
Why?
|
| Neointima | 2 | 2020 | 14 | 0.290 |
Why?
|
| Hyperplasia | 2 | 2020 | 149 | 0.280 |
Why?
|
| Adult | 11 | 2021 | 28578 | 0.270 |
Why?
|
| Vascular Patency | 2 | 2021 | 127 | 0.260 |
Why?
|
| Male | 13 | 2021 | 45684 | 0.240 |
Why?
|
| Time Factors | 3 | 2020 | 5561 | 0.230 |
Why?
|
| Female | 13 | 2021 | 49870 | 0.230 |
Why?
|
| Hematocrit | 2 | 2017 | 66 | 0.220 |
Why?
|
| Treatment Outcome | 5 | 2021 | 9167 | 0.220 |
Why?
|
| Young Adult | 4 | 2021 | 7026 | 0.220 |
Why?
|
| Aged | 9 | 2020 | 20847 | 0.210 |
Why?
|
| Risk Factors | 5 | 2020 | 5961 | 0.200 |
Why?
|
| Patient-Specific Modeling | 3 | 2019 | 24 | 0.190 |
Why?
|
| Phosphates | 1 | 2003 | 167 | 0.190 |
Why?
|
| Intermittent Pneumatic Compression Devices | 1 | 2021 | 11 | 0.180 |
Why?
|
| Counseling | 1 | 2003 | 174 | 0.180 |
Why?
|
| Dilatation | 1 | 2021 | 48 | 0.180 |
Why?
|
| Retrospective Studies | 5 | 2023 | 10273 | 0.170 |
Why?
|
| Pulsatile Flow | 1 | 2021 | 52 | 0.170 |
Why?
|
| Arm | 1 | 2021 | 100 | 0.170 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 197 | 0.160 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 378 | 0.160 |
Why?
|
| Kidneys, Artificial | 1 | 2019 | 4 | 0.150 |
Why?
|
| Veins | 1 | 2019 | 94 | 0.140 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 83 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2003 | 569 | 0.140 |
Why?
|
| Donor Selection | 1 | 2018 | 81 | 0.140 |
Why?
|
| Diabetic Nephropathies | 2 | 2009 | 90 | 0.140 |
Why?
|
| Transplant Recipients | 1 | 2018 | 157 | 0.130 |
Why?
|
| Attitude to Health | 1 | 2018 | 226 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 630 | 0.130 |
Why?
|
| Hemorheology | 1 | 2016 | 8 | 0.130 |
Why?
|
| Hepatitis C | 1 | 2018 | 184 | 0.120 |
Why?
|
| Renal Circulation | 1 | 2015 | 37 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3904 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2016 | 281 | 0.110 |
Why?
|
| Chicago | 2 | 2018 | 1505 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 7215 | 0.110 |
Why?
|
| Arteriovenous Anastomosis | 1 | 2014 | 2 | 0.110 |
Why?
|
| Kidney | 1 | 2019 | 1134 | 0.100 |
Why?
|
| Upper Extremity | 1 | 2014 | 65 | 0.100 |
Why?
|
| Phlebography | 2 | 2014 | 67 | 0.090 |
Why?
|
| Disease Progression | 1 | 2017 | 1559 | 0.090 |
Why?
|
| Erythrocyte Aggregation | 1 | 2012 | 4 | 0.090 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 882 | 0.090 |
Why?
|
| Incidence | 1 | 2015 | 1714 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2015 | 3106 | 0.070 |
Why?
|
| Blood Urea Nitrogen | 1 | 2007 | 34 | 0.070 |
Why?
|
| Outpatients | 1 | 2008 | 105 | 0.070 |
Why?
|
| Religion | 1 | 2007 | 89 | 0.060 |
Why?
|
| Spirituality | 1 | 2007 | 87 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 1877 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2007 | 213 | 0.060 |
Why?
|
| Pipecolic Acids | 1 | 2004 | 14 | 0.060 |
Why?
|
| Calcium Oxalate | 1 | 2005 | 188 | 0.050 |
Why?
|
| Hypertension, Renal | 1 | 2003 | 19 | 0.050 |
Why?
|
| Comorbidity | 1 | 2007 | 1011 | 0.050 |
Why?
|
| Hyperkalemia | 1 | 2003 | 18 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 2859 | 0.050 |
Why?
|
| Treatment Refusal | 1 | 2003 | 68 | 0.050 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2003 | 71 | 0.050 |
Why?
|
| Calcium Phosphates | 1 | 2003 | 84 | 0.050 |
Why?
|
| Kidney Calculi | 1 | 2005 | 345 | 0.050 |
Why?
|
| Educational Status | 1 | 2003 | 202 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2003 | 239 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2004 | 463 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2003 | 338 | 0.040 |
Why?
|
| Diet | 1 | 2003 | 460 | 0.040 |
Why?
|
| Quality of Life | 1 | 2007 | 1816 | 0.040 |
Why?
|
| Fear | 1 | 2018 | 88 | 0.030 |
Why?
|
| Allografts | 1 | 2018 | 207 | 0.030 |
Why?
|
| Urban Population | 1 | 2018 | 240 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2018 | 212 | 0.030 |
Why?
|
| United States | 2 | 2007 | 7764 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1127 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2018 | 542 | 0.030 |
Why?
|
| Angioplasty | 1 | 2014 | 69 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1957 | 0.030 |
Why?
|
| Liver | 1 | 2018 | 1231 | 0.030 |
Why?
|
| Thrombectomy | 1 | 2014 | 220 | 0.020 |
Why?
|
| Stents | 1 | 2014 | 422 | 0.020 |
Why?
|
| Reoperation | 1 | 2014 | 707 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 747 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1176 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 926 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1805 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 2039 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2882 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 2480 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 397 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2004 | 337 | 0.010 |
Why?
|
| Biomarkers | 1 | 2005 | 1931 | 0.010 |
Why?
|